Senior insider sale
Chief Medical Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$98.7K
22.31K shares
What this filing means
BHALLA NARINDER PAL plans to sell 22.31K shares of LEXEO THERAPEUTICS, INC. valued at approximately $98.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001959173-26-005032
Officer· Chief Medical Officer
Since Feb 2026
22.31K
Shares to sell
$98.7K
Approx. market value
22.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/29/2026
22.31KTotal acquired22.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2026 | Restricted Stock Vesting Compensation | 22.31K | — |
| Total | 22.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.31K
Market value
$98.7K
7/1/2026
Total
Units
22.31K
Value
$98.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/1/2026 | 22.31K | $98.7K | NASDAQ | Planned |
| Total | 22.31K | $98.7K | ||